<DOC>
	<DOCNO>NCT00682461</DOCNO>
	<brief_summary>This study evaluate oral tolerability nicotine prototype</brief_summary>
	<brief_title>Oral Tolerability Of Two Nicotine Dosage Forms</brief_title>
	<detailed_description />
	<mesh_term>Nicotine</mesh_term>
	<criteria>Age : Males female age least 18 year . Smoking status : a.Must smoke 5 20 cigarette per day previous 12 month . b.Must motivate quit smoking upon randomization study . Contraception : Females childbearing potential , opinion investigator , practice reliable method contraception least two month prior study participation must agree remain acceptable method contraception participate study period use study medication . Acceptable method contraception hormonal birth control , intrauterine device , double barrier method , vasectomize partner abstinence . Oral health : Must good oral health ( opinion Investigator ) clinically significant oral pathology screen . General health : Must good general health ( opinion Investigator ) clinically significant relevant abnormality medical history physical examination screening . Compliance : Understands willing , able likely comply study procedure restriction . Consent : Demonstrates understand study willingness participate evidence voluntary write informed consent receive sign date copy inform consent form . Pregnancy : Women know pregnant intend become pregnant duration study . Females childbearing potential require undergo urine pregnancy test must negative . Breastfeeding : Women breastfeed . Nicotine use : a.Is unable/unwilling stop use form tobacco . b.Is unable/unwilling stop use nicotine replacement therapy . Disease : Has medical history , opinion Investigator , would jeopardize safety subject impact validity study result , e.g . know history heart disease , recent myocardial infarction cerebrovascular accident ( i.e . within 12 week prior first study session ) , unstable angina , severe cardiac arrhythmia , diabetes peptic ulcer . Oral condition : a.Has history oral surgery ( include extraction ) within four week , operative dental work within seven day , presence clinically significant oral pathology ( determined Investigator ) include lesion , sore inflammation would interfere assessment . b.Has fix retainer , orthodontic appliance , either maxillary and/or mandibular denture appliance may interfere placement wear product . c.Has current recurrent disease could affect site application , action , absorption disposition study treatment , clinical assessment . d.Has severe gingivitis , periodontitis rampant caries , diagnose investigator . e.Has presence oral perioral ulceration include herpetic lesion time baseline ( subject lesion may reexamine subsequent appointment may able admit later date ulceration herpetic lesion heals ) . f.Has elective dentistry schedule study duration . Allergy/Intolerance : a.Has know suspected intolerance hypersensitivity study material ( closely relate compound ) state ingredient . b.Presence genetic deficiency inability metabolize aspartame phenylalanine diagnose phenylketonuria . Clinical Study/Experimental medication : a.Participation another clinical study receipt investigational drug within 30 day screen visit start study . b.Previous participation study . Substance abuse : ) Current recent ( within two year screen ) alcohol substance abuse . b ) Positive alcohol breath screen . c ) Positive urine drug screen cannabinoids , amphetamine , cocaine , ecstasy , methamphetamine morphine . Urine glucose : Positive glucose urine screen . Personnel : a.Is employee sponsor study site . b.Is member household another subject trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Nicotine Tolerability NRT</keyword>
</DOC>